[DOI] [PubMed] [Google Scholar] 12.Ueda P, Wintzell V, Melbye M, Eliasson B, Soderling J, Gudbjornsdottir S, et al
PubMed, Foer, Dinah, et al
The dosing schedule of retatrutide is as follows: Weeks 1-4: 1 mg or 2 mg once weekly (starting dose) Weeks 5-8: 4 mg once weekly Weeks 9-12: 8 mg once weekly Week 13+: 8 mg or 12 mg once weekly (Maintenance Dose) However, some trial arms tested higher doses (up to 8 mg or 12 mg as the final dose)
Retatrutide plus cagrilintide Cagrilintide, an amylin analog, combined with GLP-1 agonists produces weight loss comparable to tirzepatide
A wise approach would be to pair the GLP-1 medication for weight loss with a GLP-1 diet plan to achieve lasting results
Funding: SG is supported by a Crohns and Colitis Foundation Career Development Award